The FDA has placed clinical holds on a pair of investigational gene therapies developed to address two rare neurodevelopmental disorders in children, according to the manufacturer. In a press release, ...
Announcement follows FDA’s February 2025 decision to grant radiprodil Breakthrough Therapy designation Company remains on track to initiate Phase 3 pivotal trial of radiprodil in mid-2025 “We are ...
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for ...
The committee will vote on the application in February, Acadia said. The company intends to request a re-examination of the opinion upon the formal vote. Rett syndrome is a rare n ...
Doctors on Saturday welcomed the Supreme Courts order against the use of stem cell therapy to treat autism -- a ...
Tuesday, Taysha Gene Therapies Inc (NASDAQ:TSHA) shared initial clinical data from the first pediatric patient from the REVEAL Phase 1/2 adolescent and adult trial of TSHA-102, an investigational gene ...
A digital pet app used as a prescription digital therapeutic (PDT) to encourage children to complete prescribed therapies received high engagement and function scores from children living with ...
Taysha to have an exclusive option on new payloads, constructs, and intellectual property arising from research conducted under the agreement Agreement leverages Taysha’s existing partnership with UT ...
Hi! I am a licensed clinical psychologist in Georgia and Alabama. I have worked in the field of psychology for the past 30 years and my approach is a combination of cognitive behavior and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results